Celltrion applies for EMA approval of smaller dose formulation of Yuflyma

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

SK Chemicals launches uremia itching treatment tablet

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

LG Elec's Tennessee plant named Lighthouse Factory by WEF

LG Electronics Inc.'s home appliance factory in Tennessee, the US, has been selected as a "Lighthouse Factory" by the World Economic Forum (WEF) for...

SK-Ford JV likely to raise $4 bn via US loan program

Glendale, Kentucky -- A battery joint venture between South Korea’s SK On Co. and Ford Motor Co. is likely to raise about $4 billion in a US g...

HK inno.N gets approval to sell K-CAB in Singapore

South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...

Prestige Biopharma attains patent for solid cancer treatment antibody

Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...

SK E&S, Plug Power agree to strengthen hydrogen partnership

SK E&S CEO Choo Hyung-wook met with Plug Power CEO Andy Marsh at CES 2023 in Las Vegas on Jan. 5 to discuss ways to strengthen cooperation in th...

POSCO to enter palm oil refining market in Indonesia

POSCO International Co., a trading arm of South Korea’s steel giant POSCO Co., will build a palm oil refining plant in Indonesia to foray into...

Samsung Engineering wins $1.3 bn order to build ethylene plant in Qatar

South Korea's Samsung Engineering Co. said on Jan. 9 it has signed a 1.6 trillion won ($1.3 billion) contract to build the world's largest ethylene ...

CJ CheilJedang to expand K-food production facilities overseas

South Korean food giant CJ CheilJedang Corp. is slated to increase food manufacturing facilities globally and launch businesses in Australia, Canada...

Korea may fine Aramco-backed Hyundai Oilbank $119 mn over wastewater

South Korea is set to impose a fine of 150.9 billion won ($118.9 million) on Hyundai Oilbank Co., a local refiner backed by Saudi Aramco, for allege...

Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome

Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...

Celltrion's Remsima receives approval in 100 countries in 10 years

South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease

SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...

Hyundai to consider EV assembly plant in Saudi Arabia

Hyundai Motor Group, South Korea’s top automaker, plans to consider building an assembly plant for electric vehicles and internal combustion e...

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals

When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...

Samsung Heavy Industries lands $1.5 bn deal for offshore plant order

South Korean shipbuilder Samsung Heavy Industries has bagged a $1.5 billion order to build an offshore plant from an Asian shipper, the company reve...

Celltrion applies for FDA approval for Remsima SC

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

ToolGen, ANLBIO to jointly develop progeria treatments

South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...

JW Pharma applies for phase 3 trial in Taiwan for gout treatment

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

LG Chem in $95.5 million drug out-licensing deal with China’s Innovent

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...

S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer

South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...

LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials

LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...

POSCO, Malaysia’s Petros to join forces on carbon capture business

POSCO Holdings Inc., the holding company of South Korea’s top steelmaker POSCO, said on Monday it has joined forces with Malaysia’s ener...

SK Biopharmaceuticals launches epilepsy drug in France

South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...

LG Energy, GM to inject another $275 mn in Tennessee plant

South Korean battery maker LG Energy Solution Ltd. and General Motors Co. plan to inject an additional $275 million in a US electric vehicle battery...